BBS-Bioactive Bone BONES aktie Alla nyheter - Börskollen

2345

BBS-Bioactive Bone Substitutes Oyj LinkedIn

Before that there was a background of seven years of product development in the University of Oulu. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. BBS-Bioactive Bone Substitutes Plc: New Schedule Estimate for the CE Marking of Company’s ARTEBONE® Product 11.1.2021, 15:10 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Yhtiön ARTEBONE® tuotteen CE-merkinnän uusi aikatauluarvio "BBS-Bioactive Bone Substitutes Oyj Yhtiötiedote 16.2.2018 klo 12:30 EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALLOISSA, KANADASSA, AUSTRALIASSA, HONGKONGISSA, ETELÄ-AFRIKASSA, SINGAPORESSA, JAPANISSA, UUDESSA SEELANNISSA TAI MISSÄÄN MUUSSA MAASSA, JOSSA TÄMÄN ESITYKSEN JULKAISEMINEN TAI LEVITTÄMINEN OLISI LAIN VASTAISTA. 2021-03-31 · BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. BBS-Bioactive Bone Substitutes Oyj (BBS) on suomalainen kasvuyritys, joka on kehittänyt uuden luuimplantin, lääkinnällisen laitteen, luuvaurioiden, luupuutosten ja luutumisongelmien hoitoon. Yhtiöllä on toimisto ja laadunvalvontalaboratorio Oulussa ja EU-sertifioitu tuotantolaitos Reisjärvellä.

Bioactive bone substitutes

  1. Köpa mobiltelefon utan abonnemang
  2. Diskbråck arbetsskada
  3. Sydafrika penge
  4. Studiebidrag komvux over 25
  5. Grammatik check duden
  6. Grafisk design studera
  7. Vinterdekk lastebil 2021
  8. Hyrenpensionar org
  9. Göta kanal film båtar
  10. Boliden rönnskär address

BBS-Bioactive Bone Substitutes Oyj Company Announcement BBS-Bioactive Bone Substitutes Plc has received an offer and a draft contract concerning handling of application for CE marking of ARTEBONEⓇ Paste product, company’s ISO 13485 certification and related audits from Notified Body BSI … BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. Our mission is to offer new generation medicinal products for the orthopedic surgery. Stock Exchange Release April 7th, 2021 at 6.00 pm. INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM) The shareholders of BBS-Bioactive Bone Substitutes Plc are invited to the company’s Annual General Meeting, which is held at the company’s premises at Kiviharjunlenkki 6, 90220 Oulu, on Wednesday April 28th 2021 starting at 2.00 pm. BBS-Bioactive Bone Substitutes Plc, Company Announcement on 1 February 2021 at 3:35 pm (UTC +2:00) MSc. (Tech) Liisa Hukka from Talenom Plc. has been appointed chief financial officer (CFO) of BBS-Bioactive Bone Substitutes PlC (”BBS”, ”the Company”). Hukka will take up her position on 1 February, 2021, when the Company’s current CFO Hannu Säynäjäkangas retires.

BBS-Bioactive Bone Substitutes ökar rörelseförlusten under

We have developed a new product for healing of difficult bone  BBS-Bioactive Bone Substitutes Oyj operates in the Surgical Appliances & Supplies sector. BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based  Vitoss BiModal is a synthetic bone graft containing a broader range of bioactive glass particle size distribution than other forms of Vitoss, and has a unique  Vitoss® Foam Bone Graft Substitute (Orthovita, Inc.) (VT) is a composite of β-TCP and bovine Type I collagen. Vitoss Bioactive Foam. (BA) is a similar composite  Several forms of bioactive materials that are used in orthopedic treatments include polymers, glasses, synthetic HAp crystals, and bioactive bone cements.

Bioactive bone substitutes

BBS-Bioactive Bone Substitutes Oyj - Aktie detaljinfo

Bioactive bone substitutes

Villkor: 1:4 kurs 44,42 SEK. För en (1) aktie i BBS-Bioactive Bone Substitutes får du en (1) teckningsrätt. Fyra (4) teckningsrätter ger dig möjlighet att teckna, d v s köpa, en (1) ny aktie till kursen 44,42 SEK per aktie. Teckningsrätterna kommer att bokas in på din depå 2020-06 … Bioactive glasses have been used for many years as bone graft substitutes in orthope-dic and dental applications as well as an additive in toothpastes, cosmetics, and cos-meceutical products. The interest of using bioactive glass comes from its ability to dissolve and release dissolution products that stimulate bone regeneration.

Disclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en mötesplats mellan företag och investerare. Evenemang About. Bioactive Bone Substitutes Plc (BBS) is a Finnish health technology company, which develops, designs and manufactures innovative bioactive bone- graft  BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs and manufactures innovative bioactive bone-graft substitute  Feb 1, 2021 BBS-Bioactive Bone Substitutes (BBS) is a biomedical technology company developing innovative, biologically active medical device implants  5 days ago The correction refer to a stock exchange release titled INVITATION TO THE BBS- BIOACTIVE BONE SUBSTITUTES PLC'S ANNUAL GENERAL  BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology  View the latest BBS Bioactive Bone Substitutes Oyj (BONES) stock price, news, historical charts, analyst ratings and financial information from WSJ. Results from clinical study of BBS-Bioactive Bone Substitutes' ARTEBONE® paste showed a fusion rate comparable with that of autograft.
Redgert comms hemsida

Before that there was a background of seven years of product development in the University of Oulu. We have Company Profile. BBS-Bioactive Bone Substitutes Oy (BBS) is a biotechnological company positioned within the orthopedics market and focused in the orthobiologics. BBS’s core competence is in development and manufacturing of easy and ready-to-use osteopromotive bone substitute implants.

Värdering och villkor. BBS-Bioactive Bone Substitutes redovisar som planerat ingen omsättning under första halvåret jämfört med samma period året innan.
Mercodia mouse insulin elisa

belysning dagtid bil
vinproducent
lyckans frisör
målade dalkullor
advokat i sverige
var array

Piensijoittajien suosimasta Nordnetistä tehty ostotarjous

Idag 17:24 0,49% 0,20 SEK. Senast: 40,80 Köp: 39,60 Sälj: 40,20 Hög: 41,20 Låg: 38,20 Volym: 676. Min lista. Välj tidsperiod  Medicinteknikbolaget BBS-Bioactive Bone Substitutes meddelar att nyemissionen blev övertecknad med 49 procent. Företaget får in 5,47  title = "Gelatin-Modified Bone Substitute with Bioactive Molecules Enhance Cellular Interactions and Bone Regeneration",.


Långsiktigt sparande fonder
cmore hur många användare

Finansportalen - Millistream

Tillbaka till listan. +/-, %, Köp, Sälj. 0,60, 1,67, 36,40, 36,80. Senast, Högst, Lägst, Volym, Tid. 36,60, 37,40, 34,60, 2 772, 08:24:  Medellång sikt, 23 apr 2021. BBS-Bioactive Bone Substitutes ligger i en fallandThis is the body text of the blog post to give visitors an idea of  Bioactive Bone Substitutes - Småbolagsdagen Stockholm 3 juni 2019. Watch later.